PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC - Concepedia

Concepedia

Publication | Open Access

PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC

DOI Full Paper Access

131

Citations

29

References

2020

Year

Xiuchao Wang, Xin Li, Xunbin Wei, Haiping Jiang, Chungen Lan, Shengyu Yang, Han Wang, Yanhui Yang, Caijuan Tian, Zanmei Xu,

Signal Transduction and Targeted Therapy

References

	Year	Citations

Page 1